Research Article

nfektif Endokardite Bağlı Mekanik Mitral Kapak Dehisensi ve Faktör II, VII, IX, X (Cofakt ®) Etkisi: Olgu Sunumu

Volume: 39 Number: 2 July 22, 2014
Habib Çakır , Yüksel Beşir , İsmail Yürekli , Orhan Gökalp , Ersin Çelik , Kamil Aşar , Ali Gürbüz
TR EN

nfektif Endokardite Bağlı Mekanik Mitral Kapak Dehisensi ve Faktör II, VII, IX, X (Cofakt ®) Etkisi: Olgu Sunumu

Öz

In this paper we aimed to present our 33-year-old male case that underwent operation due to prosthetic mitral valve dehiscence secondary to infective endocarditis developed 7 months after its implantation. Generally, cases with prosthetic mitral valve dehiscence due to infective endocarditis should be electively operated whenever they could tolerate surgery hemodynamically and in terms of laboratory parameters except for emergency indications. We think that the success of surgery would increase by stabilizing the hemodynamic and laboratory parameters promptly. For this purpose Cofact® (prothrombin complex concentrate) may be used to reverse extreme INR values when this cannot be achieved by fresh frozen plasma.

Anahtar Kelimeler

İnfektif endokardit , mitral kapak , dehisens

References

  1. Günay R, Demirtaş MM, Ketenci B, Yılmaz M, Kehlibar T. İnfektif Endokarditler. Paç M, Akçevin A, Aka SA, Büket S, Sarıoğlu T (Editörler). Kalp ve damar cerrahisi. İkinci baskı. Ankara: MN Medical and Nobel Tıp Kitabevi; 2013;499-524.
  2. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective
  3. Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-413
  4. Çalkavur T. İnfektif Endokardit. Duran E (Editör). Kalp ve damar cerrahisi. Birinci baskı. İstanbul: Çapa Tıp Kitabevi. 2004;1327-34.
  5. Tiryakioğlu O, Tiryakioğlu KS, Türk T, Özkan H, Bozat T, Yavuz Ş. Aktif enfektif endokarditte ameliyat zamanlaması. Turk Goğus Kalp Damar. 2006;3:194
  6. Acar J, Michel PL, Varenne O, Michaud P, Rafik T. Surgical treatment of infective endocarditis. Eur Heart J. 1995;16:94-8.
  7. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G. Oral Anticoagulant Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:44–88.
  8. Makris M, Greaves M, Phillips WS, Kitchen S, Rosendaal FR, Preston EF. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thromb Haemost. 1997;77:477-80.
  9. Yazışma Adresi / Address for Correspondence: Dr. Habib Çakır İzmir Katip Çelebi Üniversitesi Atatürk Eğitim ve Araştırma Hastanesi Kalp ve Damar Cerrahisi Kliniği, Karaba ğlar, İZMİR Email: habibcakir35@hotmail.com geliş tarihi/received :19.08.2013 kabul tarihi/accepted:16.09.2013
MLA
Çakır, Habib, et al. “Nfektif Endokardite Bağlı Mekanik Mitral Kapak Dehisensi Ve Faktör II, VII, IX, X (Cofakt ®) Etkisi: Olgu Sunumu”. Cukurova Medical Journal, vol. 39, no. 2, June 2014, pp. 365-8, doi:10.17826/cutf.35522.